Literature DB >> 11919427

Mastocytosis: mediator-related signs and symptoms.

Mariana Castells1, K Frank Austen.   

Abstract

Patients with systemic mastocytosis present symptoms related to the tissue response to the release of mediators from mast cells and to the local mast cell burden. Such patients often have a history of chronic and acute mediator-related symptoms. Most patients have indolent disease with a good prognosis and a normal life span. Symptoms can include pruritus, flushing, syncope, gastric distress, nausea and vomiting, diarrhea, bone pain and neuropsychiatric symptoms, most of which are controlled by medication. Because there is no current cure for mastocytosis, successful therapeutic interventions rely on the recognition of mediator-related symptoms and their treatment, and established intervention approaches for the relatively uncommon leukemic concomitants. Efforts to link a particular mast cell-derived mediator to some aspect of the symptom complex depend on the known actions of the mediator and the efficacy of target-based interventions. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 11919427     DOI: 10.1159/000048188

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  20 in total

1.  Anesthetic experience in a pediatric patient with mastocytosis.

Authors:  Youn Yi Jo; Young Jin Chang; Kwang-Sub Kim; Hyun Jeong Kwak
Journal:  Korean J Anesthesiol       Date:  2011-11-23

2.  Orthopaedic case of the month: Recurrent thigh pain in a 44-year-old man.

Authors:  Adam O Burzynski; Alfredo Luis Valente; Timothy A Damron
Journal:  Clin Orthop Relat Res       Date:  2012-04-24       Impact factor: 4.176

Review 3.  [Systemic mastocytosis--definition of an internal disease].

Authors:  Jürgen Homann; Ulrich W Kolck; Andreas Ehnes; Thomas Frieling; Martin Raithel; Gerhard J Molderings
Journal:  Med Klin (Munich)       Date:  2010-09-08

Review 4.  Urticaria pigmentosa and mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatment.

Authors:  Cem Akin; Peter Valent; Luis Escribano
Journal:  Curr Allergy Asthma Rep       Date:  2006-07       Impact factor: 4.806

5.  Mast cell distribution in normal adult skin.

Authors:  A S Janssens; R Heide; J C den Hollander; P G M Mulder; B Tank; A P Oranje
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

6.  Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects.

Authors:  Gerhard J Molderings; Kirsten Meis; Ulrich W Kolck; Jürgen Homann; Thomas Frieling
Journal:  Immunogenetics       Date:  2010-09-14       Impact factor: 2.846

Review 7.  Mastocytosis: update on pharmacotherapy and future directions.

Authors:  Juan Carlos Cardet; Cem Akin; Min Jung Lee
Journal:  Expert Opin Pharmacother       Date:  2013-10       Impact factor: 3.889

Review 8.  Immunology and clinical manifestations of non-clonal mast cell activation syndrome.

Authors:  Juan-Carlos Cardet; Mariana C Castells; Matthew J Hamilton
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

Review 9.  Physiological and pathophysiological functions of intestinal mast cells.

Authors:  Stephan C Bischoff
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

Review 10.  Anesthetic considerations in pediatric mastocytosis: a review.

Authors:  Norma J Klein; Shad Misseldine
Journal:  J Anesth       Date:  2013-02-14       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.